AUD 0.21
(-2.44%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -609 Thousand AUD | 91.32% |
2023 | -7.01 Million AUD | -18.02% |
2022 | -5.94 Million AUD | -476.06% |
2021 | -1.03 Million AUD | -648.55% |
2020 | 188.03 Thousand AUD | 134.77% |
2019 | -540.79 Thousand AUD | -126.51% |
2018 | 2.04 Million AUD | 143.73% |
2017 | 837 Thousand AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | 52.5 Thousand AUD | 0.0% |
2024 FY | -6.07 Million AUD | 13.33% |
2024 Q1 | -1.93 Million AUD | 12.4% |
2024 Q2 | -3.64 Million AUD | -88.38% |
2024 Q3 | 52.5 Thousand AUD | 101.44% |
2023 Q1 | -1.97 Million AUD | 65.79% |
2023 FY | -7.01 Million AUD | -18.02% |
2023 Q4 | -2.21 Million AUD | -59.28% |
2023 Q3 | -1.38 Million AUD | 69.26% |
2023 Q2 | -4.51 Million AUD | -128.61% |
2022 Q2 | -2.67 Million AUD | -100.01% |
2022 Q1 | -1.33 Million AUD | -170.01% |
2022 FY | -5.94 Million AUD | -476.06% |
2022 Q4 | -5.77 Million AUD | -100.0% |
2022 Q3 | -2.88 Million AUD | -7.99% |
2021 Q1 | 8570.00 AUD | -99.09% |
2021 Q2 | -261.96 Thousand AUD | -3156.71% |
2021 Q3 | -249.07 Thousand AUD | 4.92% |
2021 Q4 | -494.8 Thousand AUD | -98.66% |
2021 FY | -1.03 Million AUD | -648.55% |
2020 FY | 188.03 Thousand AUD | 134.77% |
2020 Q4 | 937.16 Thousand AUD | 1334.42% |
2020 Q3 | -75.91 Thousand AUD | -122.25% |
2020 Q2 | 341.24 Thousand AUD | 100.0% |
2020 Q1 | 170.62 Thousand AUD | 125.44% |
2019 Q1 | -45.64 Thousand AUD | -109.38% |
2019 FY | -540.79 Thousand AUD | -126.51% |
2019 Q3 | -327.26 Thousand AUD | -616.94% |
2019 Q2 | -45.64 Thousand AUD | 0.0% |
2019 Q4 | -670.69 Thousand AUD | -104.94% |
2018 Q4 | 486.5 Thousand AUD | 0.0% |
2018 Q1 | 541 Thousand AUD | 0.0% |
2018 Q2 | 541 Thousand AUD | 0.0% |
2018 Q3 | 486.5 Thousand AUD | -10.07% |
2018 FY | 2.04 Million AUD | 143.73% |
2017 FY | 837 Thousand AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alcidion Group Limited | -7.64 Million AUD | 92.035% |
Artrya Limited | -14.4 Million AUD | 95.771% |
Cogstate Limited | 6.17 Million AUD | 109.866% |
Careteq Limited | -1.92 Million AUD | 68.44% |
Doctor Care Anywhere Group PLC | -16.36 Million AUD | 96.278% |
Emyria Limited | -4.26 Million AUD | 85.714% |
Global Health Limited | -1.76 Million AUD | 65.424% |
HITIQ Limited | -2.55 Million AUD | 76.21% |
Intelicare Holdings Limited | -3.1 Million AUD | 80.365% |
ImExHS Limited | -2.59 Million AUD | 76.514% |
Mach7 Technologies Limited | -1.76 Million AUD | 65.535% |
MedAdvisor Limited | 2.69 Million AUD | 122.581% |
Oakridge International Limited | -341.59 Thousand AUD | -78.281% |
Opyl Limited | -3.22 Million AUD | 81.124% |
PainChek Limited | -9.51 Million AUD | 93.599% |
Pro Medicus Limited | 112.18 Million AUD | 100.543% |
Resonance Health Limited | 593.95 Thousand AUD | 202.533% |
Singular Health Group Ltd | -3.93 Million AUD | 84.521% |
Total Brain Limited | -6.63 Million AUD | 90.817% |